Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen

Leukemia. 2005 May;19(5):879-80. doi: 10.1038/sj.leu.2403698.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Disease-Free Survival
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnostic imaging
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / radiotherapy*
  • Organometallic Compounds / therapeutic use*
  • Organophosphorus Compounds / therapeutic use*
  • Radioisotopes / therapeutic use*
  • Radionuclide Imaging
  • Reproducibility of Results
  • Samarium / therapeutic use*
  • Time Factors
  • Transplantation Conditioning / methods
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Organometallic Compounds
  • Organophosphorus Compounds
  • Radioisotopes
  • Samarium
  • samarium Sm-153 lexidronam